Lipoprotein(a), PCSK9 inhibition, and cardiovascular risk insights from the FOURIER trial

Michelle L. O’Donoghue, Sergio Fazio, Robert P. Giugliano, Erik S.G. Stroes, Estella Kanevsky, Ioanna Gouni-Berthold, Kyung Ah Im, Armando Lira Pineda, Scott M. Wasserman, Richard Češka, Marat V. Ezhov, J. Wouter Jukema, Henrik K. Jensen, S. Lale Tokgözoğlu, François Mach, Kurt Huber, Peter S. Sever, Anthony C. Keech, Terje R. Pedersen, Marc S. Sabatine

    Research output: Contribution to journal › Article › peer-review

    518 Scopus citations

    Fingerprint

    Dive into the research topics of 'Lipoprotein(a), PCSK9 inhibition, and cardiovascular risk insights from the FOURIER trial'. Together they form a unique fingerprint.

    Medicine & Life Sciences